Cardiomyopathies and heart failure are prevalent life-threatening cardiac conditions caused by impaired myocardial function, serving as key therapeutic targets for cardiac-targeted siRNA delivery. Youngen's KARDIA SHUTTLE™ delivery platform delivers drugs to cardiomyocytes with a high potency and superior safety profile. Precision cardiology targets an underlying disease-causing genetic mutation in the cardiac muscle.
